Cargando…
(18)F-FDG PET/CT total lesion glycolysis is associated with circulating tumor cell counts in patients with stage I to IIIA non-small cell lung cancer
BACKGROUND: In non-small cell lung cancer (NSCLC), (18)F-fluoro-2-deoxy-D-glucose ((18)F-FDG) uptake determined by PET and presence of circulating tumor cells (CTCs) in the peripheral blood independently predict outcomes. For (18)F-FDG PET/CT staging interpretation, standardized uptake values (SUV(m...
Autores principales: | Avella, Diego M., Manjunath, Yariswamy, Singh, Amolak, Deroche, Chelsea B., Kimchi, Eric T., Staveley-O’Carroll, Kevin F., Mitchem, Jonathan B., Kwon, Eric, Li, Guangfu, Kaifi, Jussuf T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354116/ https://www.ncbi.nlm.nih.gov/pubmed/32676315 http://dx.doi.org/10.21037/tlcr.2020.04.10 |
Ejemplares similares
-
PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer
por: Manjunath, Yariswamy, et al.
Publicado: (2019) -
Tumor-Cell–Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer
por: Manjunath, Yariswamy, et al.
Publicado: (2020) -
Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer
por: Liu, Dai, et al.
Publicado: (2018) -
Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses
por: Suvilesh, Kanve N., et al.
Publicado: (2022) -
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice
por: Li, Guangfu, et al.
Publicado: (2018)